Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Cartesian Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 92
- −2 vs. Q1 2023
- Shares held
- 56.5M
- +9.71M (+20.8%) vs. Q1 2023
- Total value
- $63.2M
- −$1.80M (−2.8%) vs. Q1 2023
- New holders
- 21
- 31 more added
- Sold out
- 23
- 20 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 94 | $90.4M |
| Q1 2026 | 83 | $43.9M |
| Q4 2025 | 67 | $37.2M |
| Q3 2025 | 68 | $60.9M |
| Q2 2025 | 66 | $66.5M |
| Q1 2025 | 72 | $86.7M |
| Q4 2024 | 68 | $119.5M |
| Q3 2024 | 64 | $110.3M |
| Q2 2024 | 62 | $88.3M |
| Q1 2024 | 70 | $35.3M |
| Q4 2023 | 80 | $37.8M |
| Q3 2023 | 87 | $57.2M |
| Q2 2023 | 92 | $63.2M |
| Q1 2023 | 95 | $65.1M |
| Q4 2022 | 86 | $62.8M |
| Q3 2022 | 97 | $104.9M |
| Q2 2022 | 93 | $79.3M |
| Q1 2022 | 102 | $71.6M |
| Q4 2021 | 106 | $185.7M |
| Q3 2021 | 103 | $216.7M |
| Q2 2021 | 101 | $219.2M |
| Q1 2021 | 98 | $245.1M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Cartesian Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −91,600−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −67,088−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −48,936−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −24,407−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −20,830−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −18,276−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −18,222−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −11,867−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −9,631−100.0% | Sold out |
| Psagot Value Holdings Ltd. / (Israel) | 0 | $0 | 0.00% | −1,981−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −145,423−100.0% | Sold out |
| CTC Capital Management, LLC | – | – | – | – | Not filed |